EASY BIO,Inc. (KOSDAQ:353810)
South Korea
· Delayed Price · Currency is KRW 4,980.00
+90.00 (1.84%)
Apr 1, 2025, 3:30 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 165.02 billion as of April 1, 2025. Its market cap has increased by 36.17% in one year.
Market Cap
165.02B
Enterprise Value
316.97B
Revenue
384.33B
Ranking
n/a
PE Ratio
8.60
Stock Price
4,980.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 165.02B, an increase of 374.77%. That is a compound annual growth rate of 38.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 162.04B | 16.15% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | 211.99B | 509.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.66T |
| Celltrion | 38.03T |
| ALTEOGEN | 18.79T |
| Yuhan | 8,537.79B |
| SK Biopharmaceuticals | 7,893.98B |
| HLB Co., Ltd. | 7,500.72B |
| Sam Chun Dang Pharm. | 3,930.51B |
| PharmaResearch | 3,506.51B |